Literature DB >> 34673011

Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated.

Neil B Varshneya1, Sherif H Hassanien2, Melissa C Holt2, David L Stevens3, Nathan K Layle2, Jonathon R Bassman2, Donna M Iula2, Patrick M Beardsley4.   

Abstract

Opioid-related fatalities involving synthetic opioids have reached unprecedented levels. This study evaluated the respiratory depressant effects of seven fentanyl analogs that have either emerged in the illicit drug supply or been identified in toxicological analyses following fatal or non-fatal intoxications. Adult male Swiss Webster mice were administered fentanyl analogs (isobutyrylfentanyl, crotonylfentanyl, para-methoxyfentanyl, para-methoxybutyrylfentanyl, 3-furanylfentanyl, thiophenefentanyl, and benzodioxolefentanyl) and their effects on minute volume as compared to mu-opioid receptor (MOR) agonist standards (fentanyl, morphine, and buprenorphine) were measured using whole body plethysmography (WBP). All drugs elicited significant (p ≤ 0.05) hypoventilation relative to vehicle for at least one dose tested: morphine (1, 3.2, 10, 32 mg/kg), buprenorphine, (0.032, 0.1, 0.32, 1, 3.2 mg/kg), fentanyl (0.0032, 0.01, 0.032, 0.1, 1, 32 mg/kg), isobutyrylfentanyl (0.1, 0.32, 1, 3.2, 10 mg/kg), crotonylfentanyl (0.1, 0.32, 1, 3.2, 10 mg/kg), para-methoxyfentanyl (0.1, 0.32, 1, 3.2, 10 mg/kg), para-methoxybutyrylfentanyl (0.32, 1, 3.2, 10 mg/kg), 3-furanylfentanyl (0.1, 0.32, 1, 3.2, 10 mg/kg), thiophenefentanyl (1, 3.2, 10, 32, 100 mg/kg), and benzodioxolefentanyl (3.2, 10, 32, 100 mg/kg). The ED50 values for hypoventilation showed a rank order of potency as follows: fentanyl (ED50 = 0.96 mg/kg) > 3-furanylfentanyl (ED50 = 2.60 mg/kg) > crotonylfentanyl (ED50 = 2.72 mg/kg) > para-methoxyfentanyl (ED50 = 3.31 mg/kg) > buprenorphine (ED50 = 10.8 mg/kg) > isobutyrylfentanyl (ED50 = 13.5 mg/kg) > para-methoxybutyrylfentanyl (ED50 = 16.1 mg/kg) > thiophenefentanyl (ED50 = 18.0 mg/kg) > morphine (ED50 = 55.3 mg/kg) > benzodioxolefentanyl (ED50 = 10,168 mg/kg). A naloxone pretreatment (10 mg/kg) attenuated the hypoventilatory effects of all drugs. These results establish that the respiratory depressant effects of these fentanyl analogs are at least in part mediated by the MOR.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fentanyl analog; Hypoventilation; Mice; Pharmacology; Respiratory depression; Synthetic opioid

Mesh:

Substances:

Year:  2021        PMID: 34673011      PMCID: PMC9022371          DOI: 10.1016/j.bcp.2021.114805

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   6.100


  58 in total

1.  Pharmacological profile of a potent, efficacious fentanyl derivative in rhesus monkeys.

Authors:  C P France; G Winger; M R Seggel; K C Rice; J H Woods
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.

Authors:  Franz Faul; Edgar Erdfelder; Axel Buchner; Albert-Georg Lang
Journal:  Behav Res Methods       Date:  2009-11

3.  Respiratory effects of morphine in awake unrestrained rats.

Authors:  R H van den Hoogen; F C Colpaert
Journal:  J Pharmacol Exp Ther       Date:  1986-04       Impact factor: 4.030

4.  Clinical pharmacology of buprenorphine: ceiling effects at high doses.

Authors:  S L Walsh; K L Preston; M L Stitzer; E J Cone; G E Bigelow
Journal:  Clin Pharmacol Ther       Date:  1994-05       Impact factor: 6.875

5.  Characterizing fentanyl use in methadone-maintained clients.

Authors:  Cynthia L Arfken; Jessica Suchanek; Mark K Greenwald
Journal:  J Subst Abuse Treat       Date:  2017-01-14

6.  Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments.

Authors:  Nicholas B Miner; William E Schutzer; Yalda Zarnegarnia; Aaron Janowsky; Randy Torralva
Journal:  Drug Alcohol Depend       Date:  2021-08-28       Impact factor: 4.492

Review 7.  Abuse of fentanyl: An emerging problem to face.

Authors:  Katarzyna Kuczyńska; Piotr Grzonkowski; Łukasz Kacprzak; Jolanta B Zawilska
Journal:  Forensic Sci Int       Date:  2018-06-02       Impact factor: 2.395

8.  Roles of μ-opioid receptors and nociceptin/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates.

Authors:  Colette M Cremeans; Erin Gruley; Donald J Kyle; Mei-Chuan Ko
Journal:  J Pharmacol Exp Ther       Date:  2012-06-28       Impact factor: 4.030

9.  Light and the laboratory mouse.

Authors:  Stuart N Peirson; Laurence A Brown; Carina A Pothecary; Lindsay A Benson; Angus S Fisk
Journal:  J Neurosci Methods       Date:  2017-04-14       Impact factor: 2.390

10.  Activation of the μ-opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure.

Authors:  Anna Åstrand; Svante Vikingsson; Ingrid Jakobsen; Niclas Björn; Robert Kronstrand; Henrik Gréen
Journal:  Drug Test Anal       Date:  2020-08-14       Impact factor: 3.345

View more
  2 in total

1.  Opioid-like adverse effects of tianeptine in male rats and mice.

Authors:  T R Baird; H I Akbarali; W L Dewey; H Elder; M Kang; S A Marsh; M R Peace; J L Poklis; E J Santos; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2022-02-24       Impact factor: 4.530

Review 2.  Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.

Authors:  Ying Han; Lu Cao; Kai Yuan; Jie Shi; Wei Yan; Lin Lu
Journal:  Neurosci Bull       Date:  2022-05-15       Impact factor: 5.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.